BIOMAT Database Logo BIOMAT Database Logo

High-risk lesions in the remnant pancreas: fate of the remnant pancreas after pancreatic resection for pancreatic cancer and intraductal papillary mucinous neoplasms. 2020

Yoshihiro Miyasaka, and Takao Ohtsuka, and Ryota Matsuda, and Yasuhisa Mori, and Kohei Nakata, and Kenoki Ohuchida, and Masafumi Nakamura
Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

Progress in diagnostic modalities, surgical procedures, and multidisciplinary treatment for pancreatic diseases has increased the number of long-term survivors after pancreatic resection. Several reports have focused on high-risk lesions (HRLs), including high-grade pancreatic intraepithelial neoplasia (PanIN), pancreatic ductal adenocarcinoma, high-grade intraductal papillary mucinous neoplasm (IPMN), and IPMN with an associated invasive carcinoma, in the remnant pancreas after partial pancreatic resection for pancreatic cancer or IPMN. The etiology of HRLs in the remnant pancreas is thought to be either isolated local recurrence of the initial lesion in the remnant pancreas or a newly developed primary lesion. Although it is difficult to distinguish between local recurrence and a new primary lesion, comparison of genetic alterations between two lesions may help with this distinction. Early detection of HRLs in the remnant pancreas may improve the prognosis of patients, and several investigators have proposed predictive factors for HRLs in the remnant pancreas after partial pancreatic resection for pancreatic cancer or IPMN. The reported short- and long-term outcomes of surgical resection of HRLs in the remnant pancreas are relatively favorable. Life-long surveillance of the remnant pancreas is recommended after partial pancreatic resection for pancreatic cancer or IPMN.

UI MeSH Term Description Entries
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D010180 Pancreatectomy Surgical removal of the pancreas. (Dorland, 28th ed) Pancreatectomies
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002288 Adenocarcinoma, Mucinous An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed) Carcinoma, Colloid,Carcinoma, Mucinous,Adenocarcinomas, Mucinous,Carcinomas, Colloid,Carcinomas, Mucinous,Colloid Carcinoma,Colloid Carcinomas,Mucinous Adenocarcinoma,Mucinous Adenocarcinomas,Mucinous Carcinoma,Mucinous Carcinomas
D002291 Carcinoma, Papillary A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed) Carcinomas, Papillary,Papillary Carcinoma,Papillary Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D018365 Neoplasm, Residual Remnant of a tumor or cancer after primary, potentially curative therapy. Minimal Residual Disease,Residual Cancer,Residual Tumor,Minimal Disease, Residual,Residual Disease, Minimal,Residual Neoplasm,Residual Tumour,Cancer, Residual,Minimal Residual Diseases,Residual Cancers,Residual Minimal Disease,Residual Minimal Diseases,Residual Neoplasms,Residual Tumors,Residual Tumours,Tumour, Residual

Related Publications

Yoshihiro Miyasaka, and Takao Ohtsuka, and Ryota Matsuda, and Yasuhisa Mori, and Kohei Nakata, and Kenoki Ohuchida, and Masafumi Nakamura
Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm.
May 2007, Journal of the American College of Surgeons,
Yoshihiro Miyasaka, and Takao Ohtsuka, and Ryota Matsuda, and Yasuhisa Mori, and Kohei Nakata, and Kenoki Ohuchida, and Masafumi Nakamura
The balance: comment on "fate of the pancreatic remnant after resection for an intraductal papillary mucinous neoplasm".
June 2012, Archives of surgery (Chicago, Ill. : 1960),
Yoshihiro Miyasaka, and Takao Ohtsuka, and Ryota Matsuda, and Yasuhisa Mori, and Kohei Nakata, and Kenoki Ohuchida, and Masafumi Nakamura
Optimal surveillance of intraductal papillary mucinous neoplasms of the pancreas focusing on remnant pancreas recurrence after surgical resection.
May 2022, BMC cancer,
Yoshihiro Miyasaka, and Takao Ohtsuka, and Ryota Matsuda, and Yasuhisa Mori, and Kohei Nakata, and Kenoki Ohuchida, and Masafumi Nakamura
Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.
November 2010, Journal of hepato-biliary-pancreatic sciences,
Yoshihiro Miyasaka, and Takao Ohtsuka, and Ryota Matsuda, and Yasuhisa Mori, and Kohei Nakata, and Kenoki Ohuchida, and Masafumi Nakamura
Intraductal papillary-mucinous adenocarcinoma in the remnant pancreas after pancreatoduodenectomy for cancer of Vater's papilla associated with intraductal papillary-mucinous adenoma.
January 2007, Journal of hepato-biliary-pancreatic surgery,
Yoshihiro Miyasaka, and Takao Ohtsuka, and Ryota Matsuda, and Yasuhisa Mori, and Kohei Nakata, and Kenoki Ohuchida, and Masafumi Nakamura
[Echo-guided spleen-preserving resection of the pancreas tail for pancreatic intraductal papillary mucinous neoplasms].
January 2009, Chirurgia italiana,
Yoshihiro Miyasaka, and Takao Ohtsuka, and Ryota Matsuda, and Yasuhisa Mori, and Kohei Nakata, and Kenoki Ohuchida, and Masafumi Nakamura
Intraductal papillary mucinous neoplasms and other pancreatic cystic lesions.
May 2008, World journal of gastroenterology,
Yoshihiro Miyasaka, and Takao Ohtsuka, and Ryota Matsuda, and Yasuhisa Mori, and Kohei Nakata, and Kenoki Ohuchida, and Masafumi Nakamura
Fate of the pancreatic remnant after resection for an intraductal papillary mucinous neoplasm: a longitudinal level II cohort study.
June 2012, Archives of surgery (Chicago, Ill. : 1960),
Yoshihiro Miyasaka, and Takao Ohtsuka, and Ryota Matsuda, and Yasuhisa Mori, and Kohei Nakata, and Kenoki Ohuchida, and Masafumi Nakamura
Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN).
June 2018, Annals of surgical oncology,
Yoshihiro Miyasaka, and Takao Ohtsuka, and Ryota Matsuda, and Yasuhisa Mori, and Kohei Nakata, and Kenoki Ohuchida, and Masafumi Nakamura
Curative resection of pancreatic ductal adenocarcinoma developing in the remnant pancreas 13 years after distal pancreatectomy for intraductal papillary mucinous neoplasms: A case report.
March 2018, Molecular and clinical oncology,
Copied contents to your clipboard!